Education
About Us
Working with TipRanks
Follow Us
Enveric Biosciences (ENVB)
NASDAQ:ENVB
ENVB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.01 - $15.45
Previous CloseN/A
Volume362.16K
Average Volume (3M)632.99K
Market Cap
$2.99M
Enterprise Value$1.28M
Total Cash (Recent Filing)$9.56K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.16
Next Earnings
May 20, 2025EPS Estimate
-3.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-21.33
Shares Outstanding2,471,656
10 Day Avg. Volume89,976
30 Day Avg. Volume632,986
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.43
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.12
Forecast
1Y Price Target
$10.00Price Target Upside754.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Enveric Biosciences News
PremiumCompany Announcements
Enveric Biosciences Prepares Presentation for February 2025
---
Ownership Overview
45.45% Insiders
11.27% Mutual Funds
3.84% Other Institutional Investors
38.82% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ENVB FAQ
What was Enveric Biosciences’s price range in the past 12 months?
Enveric Biosciences lowest stock price was $1.01 and its highest was $15.45 in the past 12 months.
What is Enveric Biosciences’s market cap?
Enveric Biosciences’s market cap is $2.99M.
When is Enveric Biosciences’s upcoming earnings report date?
Enveric Biosciences’s upcoming earnings report date is May 20, 2025 which is in 38 days.
How were Enveric Biosciences’s earnings last quarter?
Enveric Biosciences released its earnings results on Mar 31, 2025. The company reported -$4.83 earnings per share for the quarter, missing the consensus estimate of -$3.45 by -$1.38.
Is Enveric Biosciences overvalued?
According to Wall Street analysts Enveric Biosciences’s price is currently Undervalued.
Does Enveric Biosciences pay dividends?
Enveric Biosciences does not currently pay dividends.
What is Enveric Biosciences’s EPS estimate?
Enveric Biosciences’s EPS estimate is -3.45.
How many shares outstanding does Enveric Biosciences have?
Enveric Biosciences has 2,471,656 shares outstanding.
What happened to Enveric Biosciences’s price movement after its last earnings report?
Enveric Biosciences reported an EPS of -$4.83 in its last earnings report, missing expectations of -$3.45. Following the earnings report the stock price went down -5.442%.
Which hedge fund is a major shareholder of Enveric Biosciences?
Currently, no hedge funds are holding shares in ENVB
---
Enveric Biosciences Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (754.70% Upside)
$10.00 (754.70% Upside)
Crowd Wisdom
Positive
Last 7 Days ▲ 6.8%
Last 30 Days ▼ 4.2%
Last 30 Days ▼ 4.2%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.59%
12-Months-Change
Fundamentals
Return on Equity
-356.82%
Trailing 12-Months
Asset Growth
-49.61%
Trailing 12-Months
Company Description
Enveric Biosciences
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
---
ENVB Stock 12 Month Forecast
Average Price Target
$10.00
▲(754.70% Upside)
Technical Analysis
Best Analysts Covering ENVB
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-55.60%
reiterated a buy rating last month
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -55.60% per trade.
---